NCT07379047 2026-01-30GISTAR-1Ningbo Newbay Technology Development Co., LtdPhase 2/3 Not yet recruiting255 enrolled
NCT02085148 2024-04-22A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyBayerPhase 1 Completed62 enrolled
NCT01646593 2014-12-15Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard TherapyBayerNo longer available